Creating Hope Reauthorization Act of 2024
Last action on Feb 4, 2026Referred to the House Committee on Energy and Commerce.
Take Action
Summary
Creating Hope Reauthorization Act of 2024
This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)
Lifecycle of the Bill
Introduced in House
Feb 4, 2026
Introduced in House
Feb 4, 2026
Referred to the House Committee on Energy and Commerce.
Feb 4, 2026
